Related references
Note: Only part of the references are listed.Randomized trial of the combination of lomeguatrib and temozolomide compared with temozolomide alone in chemotherapy naive patients with metastatic cutaneous melanoma
Malcolm Ranson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Metastatic colorectal cancer
Piercarto Saletti et al.
CANCER TREATMENT REVIEWS (2006)
Exploiting the role of O6-methylguanine-DNA-methyltransferase (MGMT) in cancer therapy
Ami Sabharwal et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA-alkyltransferase:: Phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumors
M Ranson et al.
CLINICAL CANCER RESEARCH (2006)
Screening for colorectal cancer in average-risk populations
David Lieberman
AMERICAN JOURNAL OF MEDICINE (2006)
The emerging role of DNA repair proteins as predictive, prognostic and therapeutic targets in cancer
S Madhusudan et al.
CANCER TREATMENT REVIEWS (2005)
Phase II trial of the O6-alkylguanine DNA alkyltransferase inhibitor O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea in advanced melanoma
TF Gajewski et al.
CLINICAL CANCER RESEARCH (2005)
Temozolomide in the treatment of solid tumours: current results and rationale for dosing/scheduling
MJ Payne et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2005)
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer:: A randomized GERCOR study
C Tournigand et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: An updated meta-analysis
P Piedbois
JOURNAL OF CLINICAL ONCOLOGY (2004)
Effect of O6-(4-bromothenyl)guanine on different temozolomide schedules in a human melanoma xenograft model
MR Middleton et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Phase II trial of carmustine plus O6-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma
JA Quinn et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
O-6-methylguanine-DNA methyltransferase (MGMT) as a determinant of resistance to camptothecin derivatives
R Okamoto et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2002)
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
JY Douillard et al.
LANCET (2000)
Share Paper
